非小细胞肺癌组织中D2-40标记阳性淋巴管密度和E-钙黏蛋白的表达及其临床意义研究(3)
 |
| 第1页 |
参见附件。
Figure3. Pulmonary adenocarcinoma with reduced E-cadherin expression(+)(Immunohistochemical SP ×400)
Table 1. LVD marked by D2-40 in the patients enrolled in the study and the correlation with expression of E-cadherin
Table 2. The expression of E-cadherin in the patients enrolled in the study and the clinicopathologic characteristics of NSCLC
参考文献
[1] Kahn H J, Marks A.A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors [J]. Lab Invest, 2002, 82 (9) 1225-57.
[2] Hirohashi S. Inactivation of the E-cadherin-medaated cell adhesion system in human cancers[J]. AM J Pathol, 1998, 153: 333-9.
[3] WEIDNER N. Tumor angiogenesis: review of current applications in tumor prognostication [J]. Semin Diagn Pathol, 1993, 10(4):302-13.
[4] 韩安家，熊敏，李智等。上皮钙依赖粘附素相关分子在乳腺浸润性小叶癌和导管癌中的表达及意义。中华病理学杂志，2001, (30): 27-30.
[5] KAHN HJ, BAILEY D, MARKS A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of anglosarcomas[J]. Mod Pathol, 2002, 15(4): 434-40.
[6] Vleugel MM, Bos R, van der Groep P, et al. Lack of lymphangiogenesis during braest carcinogenesis[J]. J Clin Pathol, 2004, 57(7): 746.
您现在查看是摘要介绍页，详见PDF附件。